1 / 10

HIV Drug Market Research & Industry Analysis, 2022

HIV Drug Market report, published by Allied Market Research, forecasts that the global market is expected to garner $26,458 million by 2022, registering a CAGR of 3.7% during the period 2016 - 2022. The multi-class combination drug segment held over one-third share of the total market in 2015.<br><br>Read this Research Report here:- https://www.alliedmarketresearch.com/hiv-drugs-market<br>

deshmukhdeepak009
Download Presentation

HIV Drug Market Research & Industry Analysis, 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HIV Drug Market Opportunities and Forecasts, 2014 - 2022 Pages: 163 Published: 2017

  2. HIVDRUG MARKET MARKET  North America and Europe are expected to dominate the global HIV drug market during the forecast period, while emerging countries in Asia-Pacific and Latin America are expected to offer significant growth opportunities. HemaliNarkhede

  3. HIVDRUG MARKET MARKET OVERVIEW • HIV Drug Market report, published by Allied Market Research, forecasts that the global market is expected to garner $26,458 million by 2022, registering a CAGR of 3.7% during the period 2016 - 2022.  • The multi-class combination drug segment held over one-third share of the total market in 2015. • Multi-class combination drugs segment had accounted for more than one-third revenue of the overall HIV drug market in 2015, owing to increase in adoption of combination drugs from this medication class due to their better results in the control of HIV & related coinfections and their ease in consumption & adherence.  • Read more at : https://www.alliedmarketresearch.com/hiv-drugs-market

  4. HIVDRUG MARKET MARKET KEY BENEFITS • The study provides an in-depth analysis of the HIV drugs market, with current trends and future estimations to elucidate the imminent investment pockets. • It presents a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities. • Extensive analysis of the HIV drug market, by medication class, assists in the effective treatment of HIV/AIDS. • Key players are profiled and their strategies are analyzed thoroughly, which predicts the competitive outlook of the market.

  5. HIVDRUG MARKET MARKET TOP INVESTMENT POCKETS

  6. HIVDRUG MARKET MARKET KEY FINDINGS • In 2015, multi-class combination drugs segment was the leading medication class segment. • The branded drug Triumeq of multi-class combination drug segment is estimated to grow at the CAGR of 20.7%. • North America market is projected to grow at a CAGR of 3.4% during analysis period. • The Nucleoside Reverse Transcriptase Inhibitors (NRTIs) segment is estimated to grow at the CAGR of 0.4%.

  7. KEY PLAYERS IN INDUSTRY • BoehringerIngelheim International GmbH • Merck & Co., Inc. • ViiV Healthcare • AbbVie • F. Hoffmann-La Roche Ltd. • Teva Pharmaceutical Industries Ltd. • Bristol-Myers Squibb • Gilead Sciences, Inc. • Johnson & Johnson • Cipla Limited • Download Sample Report : • https://www.alliedmarketresearch.com/request-free-sample/1867

  8. HIVDRUG MARKET SEGMENTATION

  9. HIVDRUG MARKET MARKET BYGEOGRAPHY North America Europe Asia-Pacific LAMEA

  10. Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/hiv-drugs-market Follow Us On

More Related